Intensive blood pressure control not linked to changes in cerebral perfusion in patients with cerebral small vessel diseaseMarch 14, 2018
In patients with severe cerebral small vessel disease, a strategy of intensive blood pressure control did not significantly alter whole brain blood flow when compared to standard blood pressure control.
Women with gestational diabetes have a greater risk of developing T2D and cardiovascular events than women who were not previously diagnosed with the disease.
Breastfeeding duration and frequency may help reduce hypertension risks.
Team-based, multilevel implementation strategies were the most effective at reducing systolic blood pressure.
Addition of a new class of antihypertensive drugs to existing treatment greatly decreases SBP in previously medicated patients with HT.
The AAFP continues to use the 2014 JNC8 guideline instead of the 2017 AHA/ACC update.
Blood pressure decreases more than a decade before death in patients older than 60 years.
The AHA and ACC have released a new guideline that categorizes more US adults as hypertensive.
Among women, but not men, mid-adulthood hypertension correlated with a 65% increased dementia risk.
The statement includes advances in care since the ADA's last position statement was published in 2003.
The AAP has released an updated clinical practice guideline for the diagnosis and management of high blood pressure in children.
Researchers found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking.
Blood pressure levels below the recommended targets lower risk of CVD and all-cause mortality.
The USPSTF recommends that pregnant women receive screening for preeclampsia with blood pressure measurements throughout pregnancy.
Researchers observed a higher incidence of hypertension in patients with knee osteoarthritis compared with patients without osteoarthritis.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.
The ACP and the AAFP has released a joint recommendation for the pharmacologic treatment of hypertension in adults aged 60 years and older.
The prevalence of elevated blood pressure rates shifted from high-income to low- and middle-income countries.
Readmission was more common among publically insured, black patients presenting with comorbidities including hypertension and diabetes.
Baseline renal function tests may predict the risk of preeclampsia and preterm birth for pregnant women with hypertension.
Even those who are in overall poor health and medically frail could benefit from hypertension interventions.
Addressing factors that lead to lack of adherence to antihypertensive therapy in elderly patients is crucial to improving outcomes.
Women who had gestational diabetes may be able to reduce their risk of developing hypertension by eating a healthy diet.
Results from a study presented at ACC in Chicago suggest that statins can be more widely used in patients considered to be intermediate risk for cardiovascular disease.
Renin angiotensin system blockers have similar risks and outcomes compared with other antihypertensive agents for patients with diabetes.
Investigators found an increased risk of ischemic stroke among all patients within 21 days following initiation of alpha-blocker therapy.
Premature birth has been associated with a number of adverse health conditions.
Treating hypertension can reduce the risk of major cardiovascular disease events regardless of blood pressure at the start of treatment.
The FDA has approved Uptravi (selexipag) for the treatment of pulmonary arterial hypertension in adult patients.
New guidelines released by the American Heart Association and the American Thoracic Society are the first for the diagnosis and treatment of pediatric pulmonary hypertension.